IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Australia, U.K. Authorities Okay Ranbaxy’s Indian Plant

9:47 AM MDT | April 3, 2009 | Deepti Ramesh

Ranbaxy Laboratories (Gurgaon, India) says that the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) and Australia’s drug regulatory body Therapeutic Goods Administration (Canberra) have issued GMP certificates for Ranbaxy’s Paonta Sahib, India facility, following a joint audit conducted last October. MHRA’s approval will cover U.K. product filings and also apply to product filings for the entire European Union, Ranbaxy says. The U.S. FDA said last month that the Paonta Sahib facility falsified data and test...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa